Compass Therapeutics, Inc. Share Price OTC Markets
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
OTC Markets Traded|
Real-time Estimate
Cboe BZX
07:52:54 28/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2.465 USD | -30.56% |
|
+32.67% | - |
| Market Cap | 45Cr 39Cr 36Cr 33Cr 63Cr 4.33TCr 63Cr 431.87Cr 168.83Cr 2.18TCr 170.39Cr 166.71Cr 7.23TCr | P/E 2026 * |
-5.03x | P/E 2027 * | -4.56x |
|---|---|---|---|---|---|
| Enterprise Value | 30Cr 26Cr 24Cr 22Cr 42Cr 2.9TCr 42Cr 289.13Cr 113.02Cr 1.46TCr 114.07Cr 111.61Cr 4.84TCr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 14.3x |
| Free-Float |
87.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Compass Therapeutics, Inc.
| 1 day | -30.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
CEO | Chief Executive Officer | 65 | 28/05/2024 |
Barry Shin
DFI | Director of Finance/CFO | 54 | 09/12/2024 |
Bing Gong
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Schuetz
BRD | Director/Board Member | 65 | 01/01/2014 |
Phil Ferneau
BRD | Director/Board Member | 64 | 01/01/2015 |
Carl Gordon
CHM | Chairman | 61 | 01/01/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -30.56% | +32.67% | - | - | 45Cr | |
| +3.31% | -3.70% | +61.03% | +103.64% | 7.06TCr | |
| -0.86% | -0.27% | +49.29% | +91.57% | 6.61TCr | |
| -6.31% | -10.95% | +1.84% | -13.98% | 2.8TCr | |
| -2.33% | -6.05% | -12.45% | +446.53% | 2.65TCr | |
| +0.30% | -0.69% | +63.18% | +11.93% | 2.64TCr | |
| +1.02% | +6.43% | +269.42% | +420.34% | 2.04TCr | |
| +0.21% | +1.07% | +34.82% | -17.34% | 2.02TCr | |
| -1.91% | -4.37% | +13.33% | +531.29% | 1.6TCr | |
| -1.47% | +0.90% | +43.97% | +146.01% | 1.37TCr | |
| Average | -3.85% | +0.99% | +58.27% | +191.11% | 3.2TCr | |
| Weighted average by Cap. | -0.32% | +0.65% | +55.49% | +152.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 2.24Cr 1.92Cr 1.8Cr 1.65Cr 3.1Cr 213.87Cr 3.11Cr 21Cr 8.33Cr 107.79Cr 8.41Cr 8.23Cr 356.74Cr |
| Net income | -9.4Cr -8.07Cr -7.56Cr -6.92Cr -13Cr -898.18Cr -13Cr -89Cr -35Cr -452.68Cr -35Cr -35Cr -1.5TCr | -11Cr -9.43Cr -8.83Cr -8.08Cr -15Cr -1.05TCr -15Cr -104.52Cr -41Cr -528.66Cr -41Cr -40Cr -1.75TCr |
| Net Debt | -15Cr -13Cr -12Cr -11Cr -21Cr -1.43TCr -21Cr -142.75Cr -56Cr -722.03Cr -56Cr -55Cr -2.39TCr | -13Cr -11Cr -11Cr -9.79Cr -18Cr -1.27TCr -18Cr -126.57Cr -49Cr -640.2Cr -50Cr -49Cr -2.12TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CMPX Stock
- CMPX Stock
Select your edition
All financial news and data tailored to specific country editions
